Form 4: AngioDynamics Director Lorinda Burgess Acquires and Disposes of Shares in Recent Transaction
SEC Form 4 Filing
Director Lorinda Burgess receives restricted stock units and disposes of shares of AngioDynamics, Inc.
Summary
- On July 17, 2024, Lorinda Burgess, a director of AngioDynamics Inc., acquired 20,541 shares of common stock.
- These shares were granted as restricted stock units as annual compensation for her service as a director.
- The restricted stock units vested immediately upon grant.
- Burgess also disposed of 37,582 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a director's stock transactions. The sentiment is neutral as it simply reports facts without expressing any opinion or forward-looking statements.
Positives
- The acquisition of restricted stock units indicates continued alignment of the director's interests with the company's performance.
Negatives
- The disposal of 37,582 shares by the director could be interpreted negatively by some investors.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor their activity.
Stakeholder Impact
- Shareholders may be interested in the director's stock transactions as an indicator of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 07/17/2024 | Date of transaction: acquisition and disposal of shares. |
| 07/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.